Nisonic secures NOK 16M in an investment round including Hadean Ventures, SINTEF Venture and Investinor.
NiSonic, a Trondheim, Norway-based medical company maufacturing an advanced ultrasound technology to measure the pressure in the brain (intracranial pressure) in a harmless and cost effective way, announced securing NOK 16M ($2M) in capital investment.
NiSonic, founded in 2017 as a spinoff from SINTEF for commercializing technology based on collaboration between researchers at SINTEF and neurosurgeons at the Red Cross War Memorial Children’s Hospital in Cape Town, South Africa. The company develops products that allow physicians to diagnose and monitor increased intracranial pressure (ICP) in an easier and cost-effective way by providing a software solution that analyzes ultrasound images of the eye to monitor increased ICP, and that can be integrated into ultrasound devices on the market, enabling widespread use among physicians and other health workers.
The core team consists of Reidar Brekken, Tormod Selbekk, Eli Grong Aursand and Jan Biti (CEO).